Intro Pullout Text Widget

Open Heart

is an open access journal by BMJ and BCS, publishing original research in cardiovascular medicine.

Open Heart is dedicated to publishing high quality, peer reviewed medical research in all disciplines and therapeutic areas of cardiovascular medicine. Research is published across all study phases and designs, from protocols to phase I trials to meta-analyses, including small or specialist studies. Opinionated discussions on controversial topics are welcomed.

Open Heart is an official journal of the British Cardiovascular Society.

Follow the journal via Twitter and Facebook.

Editor-in-Chief: Dr Pascal Meier, Hospital of Graubunden (Switzerland) and Royal Brompton Hospital (UK)
Editorial team

COVID-19: a message from BMJ >>

BCS COVID-19 resource hub >>

Current Issue

Authors

Open Heart considers submissions of a variety of article types, including original research articles, study protocols and occasional review articles. Responses to published work are also welcomed.

Information is also provided on editorial policies and open access.

This is an open access journal that levies an Article Publishing Charge (APC). Discounts and waivers are available; details are provided in the Author Information section.

All manuscripts should be submitted online.

Author information

Submit a paper

Twitter Feed

Open Heart @Open_HeartBMJ

Characteristics and in-hospital outcomes of patients undergoing balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a time-trend analysis from the Japanese nationwide registry
https://t.co/n3qLqGaA7B https://t.co/i4oxkSz5QI

View on Twitter

Open Heart @Open_HeartBMJ

Using genetics to detangle the relationships between red cell distribution width and cardiovascular diseases: a unique role for body mass index
https://t.co/yzxREk7THu

View on Twitter

Open Heart @Open_HeartBMJ

Impact of risk factors for major cardiovascular diseases: a comparison of life-time observational and Mendelian randomisation findings.
https://t.co/SYvXzAyomD

View on Twitter

Open Heart @Open_HeartBMJ

Long-term outcomes after treatment of in-stent restenosis using the Absorb everolimus-eluting bioresorbable scaffold - a good idea?
https://t.co/IJcUzEZU8m https://t.co/F1PDLC8BJC

View on Twitter

Open Heart @Open_HeartBMJ

Effect of moderate potassium-elevating treatment in long QT syndrome: the TriQarr Potassium Study does not support that moderate elevation of K has a role in long-term anti arrhythmic prophylaxis.
https://t.co/Gtt0RobCto https://t.co/pzcZVAUGmJ

View on Twitter

Open Heart @Open_HeartBMJ

Long-term survival in patients with isolated pulmonary valve stenosis: a not so benign disease?
https://t.co/YHUMUDA6ZE https://t.co/EuxS1frmwg

View on Twitter

Intro Pullout Text Widget

Open Heart

Authors

Latest Articles

Arrhythmias and sudden death:

Investigating the efficacy of chest pressure for direct current cardioversion in atrial fibrillation: a randomised control trial protocol (Pressure-AF)

Heart failure and cardiomyopathies:

Discrepancy between left ventricular hypertrophy by echocardiography and electrocardiographic hypertrophy: clinical characteristics and outcomes

Interventional cardiology:

Predictors of clinical outcome following transcatheter aortic valve implantation: a prospective cohort study

Arrhythmias and sudden death:

Effect of moderate potassium-elevating treatment in long QT syndrome: the TriQarr Potassium Study

Correction:

Correction: Characteristics of infective endocarditis in a cancer population

FREE: Latest COVID-19 Content

SPECIAL POPULATIONS:

Echocardiography in suspected coronavirus infection: indications, limitations and impact on clinical management

HEALTH CARE DELIVERY, ECONOMICS AND GLOBAL HEALTH CARE:

Impact of COVID-19 on the imaging diagnosis of cardiac disease in Europe

CORONARY ARTERY DISEASE:

Review of Irish patients meeting ST elevation criteria during the COVID-19 pandemic

CORONARY ARTERY DISEASE:

Effects of lockdown on acute coronary syndrome incidence in an area without community transmission of COVID-19

HEART FAILURE AND CARDIOMYOPATHIES:

Vascular comorbidities worsen prognosis of patients with heart failure hospitalised with COVID-19

Most Read Articles

Editorial:

Melatonin may decrease risk for and aid treatment of COVID-19 and other RNA viral infections

Viewpoint:

Editorial:

Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19

Health care delivery, economics and global health care:

Relationships between hyperinsulinaemia, magnesium, vitamin D, thrombosis and COVID-19: rationale for clinical management

Editorial:

Anti-inflammatory activity of ivermectin in late-stage COVID-19 may reflect activation of systemic glycine receptors

Twitter Feed